Literature DB >> 32159447

Correlation Between Biofilm Formation and Antibiotic Resistance in MRSA and MSSA Isolated from Clinical Samples in Iran: A Systematic Review and Meta-Analysis.

Motaharesadat Hosseini1, Abbas Shapouri Moghaddam2, Solmaz Derakhshan3, Seyed Mohammad Amin Hashemipour4, Mehdi Hadadi-Fishani5, Aliyar Pirouzi6, Azad Khaledi7.   

Abstract

Objectives: This study aimed at reviewing the correlation between biofilm formation and antibiotic resistance in methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive S. aureus (MSSA) isolates. Materials and
Methods: This review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocols. The literature search was conducted in PubMed, Web of Science (ISI), and Scopus databases. Combinations of Mesh terms such as "biofilms" OR "biofilm formation," AND "Drug Resistance" OR "Antimicrobial Drug Resistance" OR "Antibiotic Resistance" AND "Staphylococcus aureus" OR "Methicillin-resistant Staphylococcus aureus" or "MRSA" AND "Methicillin-sensitive Staphylococcus aureus" OR "MSSA" AND "biofilm-related genes" AND "Prevalence" AND "Iran" were searched. Two reviewers independently searched the databases. Analyses were performed in Comprehensive Meta-Analysis software. The random-effects model was used to obtain the combined prevalence with a 95% confidence interval (CI).
Results: The combined prevalence of MRSA retrieved from Iranian clinical samples was 48.3% (95% CI: 40.8-55.9). The pooled rate of biofilm formation in MRSA strains was reported as 80.9% (95% CI: 67.8-89.4). Overall, 52.9%, 45.3%, and 22.5% of MRSA isolates were strong, moderate, and weak biofilm producers, respectively. The highest frequency of biofilm-related genes was observed for icaD gene (67.7%) followed by clfA gene with a frequency of 64.7%. Among seven studies that addressed the relationship between biofilm formation and antibiotic resistance, six reported positive associations. Conclusions: Regarding the MRSA strains, they had a significantly higher ability of biofilm formation than MSSA strains; therefore, preventive measures against infections caused by them are required.

Entities:  

Keywords:  antibiotic resistance; biofilm; correlation; methicillin-resistant Staphylococcus aureus

Mesh:

Substances:

Year:  2020        PMID: 32159447     DOI: 10.1089/mdr.2020.0001

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  5 in total

1.  Targeted inhibition of methicillin-resistant Staphylococcus aureus biofilm formation by a graphene oxide-loaded aptamer/berberine bifunctional complex.

Authors:  Yi Ning; Xiaoqi Wang; Pingan Chen; Shiwu Liu; Jue Hu; Rong Xiao; Ling Li; Fangguo Lu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

2.  Mupirocin-Resistant Staphylococcus aureus in Iran: A Biofilm Production and Genetic Characteristics.

Authors:  Samira Zamani; Anis Mohammadi; Bahareh Hajikhani; Parnaz Abiri; Maryam Fazeli; Mohammad Javad Nasiri; Masoud Dadashi; Mehdi Goudarzi; Mehrdad Haghighi
Journal:  Biomed Res Int       Date:  2022-01-15       Impact factor: 3.411

3.  Biofilm Formation of Helicobacter pylori in Both Static and Microfluidic Conditions Is Associated With Resistance to Clarithromycin.

Authors:  Paweł Krzyżek; Paweł Migdał; Rossella Grande; Grażyna Gościniak
Journal:  Front Cell Infect Microbiol       Date:  2022-03-25       Impact factor: 6.073

4.  Biofilm Alterations on the Stepwise Acquisition of Fluconazole-resistant Candida Albicans Isolates.

Authors:  Na-Na Song; Guan-Yu Qian; Hai-Lin Zheng; Xiao-Wei Zhou; Huan Mei; Dong-Mei Li; Xiao-Fang Li; Wei-Da Liu
Journal:  Int J Dermatol Venereol       Date:  2022-01-19

5.  Genetic analysis of methicillin-susceptible Staphylococcus aureus clinical isolates: High prevalence of multidrug-resistant ST239 with strong biofilm-production ability.

Authors:  Hossein Goudarzi; Mehdi Goudarzi; Fattaneh Sabzehali; Maryam Fazeli; Alireza Salimi Chirani
Journal:  J Clin Lab Anal       Date:  2020-07-21       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.